ccRCC harbor the traits of primary resistance to chemotherapy and radiation therapy, mainly due to the dysregulation of vonhippel-lindau- hypoxia-inducible factor- vascular endothelial growth factor (VHL-HIF-VEGF) pathway resulting from VHL gene mutation (Figure 7). This evidence concerns the gene VEGFA and nonpapillary renal cell carcinoma.